718610-63-0

Upstream product

• 25519-80-6 4-(benzoyl)piperidine hydrochloride 
• 515154-31-1 4-benzoyl-1-methanesulphonylpiperidine 
• 867-13-0 diethoxyphosphoryl-acetic acid ethyl ester 

Downstream Products

• 718610-64-1 ethyl 3-phenyl-3-(N-methanesulphonylpiperidin-4-yl)propionate 
• 718610-17-4 3-(1-methanesulphonylpiperidin-4-yl)-3-phenylpropionaldehyde 
• 718610-16-3 N-(3-phenyl-3-[1-methanesulphonyl-piperidin-4-yl]propyl)-4-[2-(4-fluorophenylsulphonyl)ethyl]piperidine 

Relevant academic research and scientific papers

NOVEL PIPERIDINE/8-AZABICYCLO [3.2.1] OCTAN DERIVATIVES AS MODUILATORS OF CHEMOKINE RECEPTOR CCR5

Compounds of formula (I) wherein neither R4 nor R5 is hydrogen; compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).

PIPERIDINE DERIVATIVES AS CCR5 RECEPTOR MODULATORS

Compounds of formula (I) wherein R1, R2, R3, A and n are as defined; and X is S(O)2 NR4R5 or NR6S(O)2R7; compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).

NOVEL PIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR CCR5

Compounds of formula (I): wherein R1, R2, R3, R4, R5, A and X are as defined herein; compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).

NOVEL PIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR CCR5

Compounds of formula (I) wherein R1, R2, R3, R4, A, X, m and n are as defined; compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).